Aspirin in Acute Pneumonia in the Elderly: a Multicenter, Double-blind, Randomized, Placebo-controlled Trial.

PHASE3Not yet recruitingINTERVENTIONAL
Enrollment

600

Participants

Timeline

Start Date

February 28, 2026

Primary Completion Date

May 31, 2029

Study Completion Date

June 30, 2029

Conditions
Acute PneumoniaElderly Person
Interventions
DRUG

Acetylsalicylic acid/Aspirin (100 mg)

Patients will receive 100 mg acetylsalicylic acid (or Aspirin) orally (tablet) once a day (or intravenously if oral administration is not possible in the acute phase of pneumonia), introduced within 84 hours of pneumonia diagnosis, for 90 days.

DRUG

Placebo acetylsalicylic acid (100 mg) / 0.9% sodium chloride

patients in the placebo group will receive 100 mg placebo acetylsalicylic acid orally (tablet) once a day (or intravenously if oral administration is not possible in the acute phase of pneumonia), introduced within 84 hours of pneumonia diagnosis, for 90 days.

All Listed Sponsors
lead

Centre Hospitalier Universitaire Dijon

OTHER